KeithDanielsKaufmanMD

Diabetes, Lipid Metabolism

Vice President, Project Leadership & Management, Merck Research Laboratories

Dr. Kaufman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
University of California San Francisco School of MedicineClass of 1983

PubMed

3 citations
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism.
R Ravi Shankar, Suneri Shah, Hee-Koung Joeng, Geraldine Mendizabal, Julia R DiBello
The Journal of Clinical Endocrinology and Metabolism. 2022-06-16
14 citations
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
Muhammad Yazid Jalaludin, Asma Deeb, Philip Zeitler, Raymundo Garcia, Ron S. Newfield
Pediatric Diabetes. 2021-11-14
14 citations
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
R. Ravi Shankar, Philip Zeitler, Asma Deeb, Muhammad Yazid Jalaludin, Raymundo Garcia
Pediatric Diabetes. 2021-11-14

Journal Articles

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficienc...
Keith Kaufman, MD, Diabetes, Obesity and Metabolism